Borgess Internal Medicine Kalamazoo, MI - 49048

Borgess Internal Medicine is categorized under Blood Related Health Services in Kalamazoo, MI .

Borgess Internal Medicine was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact April Karakula, Office Manager at the company’s branch by writing to 1701 Gull Road, Kalamazoo, Michigan MI 49048 or by phoning (269) 226-5290. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Borgess Internal Medicine
Contact Person: April Karakula, Office Manager
Address: 1701 Gull Road, Kalamazoo, Michigan 49048
Phone Number: (269) 226-5290
Website Address: borgess.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Blood Related Health Services
SIC Code: 8099
NAICS Code: 6211110
Share This Business:

Borgess Internal Medicine was started in 0 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact April Karakula, Office Manager for inquiries that concern Borgess Internal Medicine by calling the company number (269) 226-5290, as your correspondence is most welcome. Additionally, the physical location of the branch of Borgess Internal Medicine can be found at the coordinates 42.30641,-85.55804 as well as the street address 1701 Gull Road in Kalamazoo, Michigan 49048.

For its online presence, you may visit Borgess Internal Medicine’s website at borgess.com and engage with its social media outlets through on Twitter and on Facebook.